Access our review in Journal of Translational
Access our publication in Targeted Oncology viahttps://doi.org/10.1007/s11523-019-00667-z
European Antibody Congress 2019
Egotumab, a human antibody targeting GOLPH2 in colorectal cancer was presented at the European Antibody Congress 2019 in Basel, Switzerland.
3rd Annual Next Gen Immune-Oncology Congress 2019
Egotumab, a human antibody against colorectal cancer, was presented at the Poster Session on 15.03.2019 in London, UK.
European Antibody Congress 2018
Egotumab, a human antibody against colorectal cancer, was presented in a keynote lecture on Wednesday 31.10.2018 in Basel, Switzerland.
BaseLaunch selected CUREAB for phase I of its accelerator program in 2018
we strive to provide patients with novel next generation antibodies for better
cancer therapies in tumours with a high medical need. Colorectal Cancer will be the beginning.